news

Our latest
Press Releases & Updates

Latest press releases

RetinAI Announces Strategic Partnership with Eyestem to Innovate Geographic Atrophy Clinical Research Using State-of-the-Art AI Technology

RetinAI and Retina Consultants of America Join Forces to build the Most Comprehensive U.S.-based Real World Evidence Database in Ophthalmology

RetinAI Medical AG and Retina Consultants of America (RCA) forge a strategic partnership to revolutionize Ophthalmology data. Leveraging RetinAI's advanced AI technologies and RCA's expansive clinic network, this alliance is set to develop the largest Real World Evidence (RWE) U.S.-based database in the field.

RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence

RetinAI Medical AG has announced a partnership with Boehringer Ingelheim to improve patient outcomes in geographic atrophy (GA). RetinAI's AI tools for identifying novel biomarkers will be used to analyze Boehringer Ingelheim's imaging datasets from clinical studies and real-world evidence to identify additional biomarkers and predictors of disease progression. This partnership aims to accelerate the development of novel treatments and enable earlier and more precise diagnosis, contributing to Boehringer Ingelheim's vision of preventing vision loss and blindness caused by retinal diseases.

RetinAI’s AI Algorithms Enrich Clinical Research and Improve Patient Care

RetinAI Medical AG has announced the acceptance of five abstracts for poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference taking place from April 23rd to 26th, 2023 in New Orleans. These studies highlight the potential of RetinAI’s Discovery platform and its certified and research use only (RUO) AI models to revolutionize healthcare decisions, improve patient care, help accelerate clinical trials, and drive better decisions for patient management.

124E International Congress de la SFO [MAY'18]

RetinAI had the pleasure to present in the 124e Congrès International de la Société Française d'Ophthalmologie in the session: 'L'impact de l'intelligence artificielle dans la santé visuelle', organised by Optic 2000 in Paris! Wonderful day presenting how AI and machine learning are changing the current paradigm of screening and monitoring of eye diseases.

‍

ARVO 2018 Honolulu - Hawaï [APRIL-MAY'18]

RetinAI is getting ready for the American Research in Vision and Ophthalmology #ARVO2018 in Hawaii! Come to our booth 1039 if you want to learn about how #AI is changing the world of ophthalmic care!

Bilan Magazine TOP 50 Startups in which to invest 2018 [FEBRUARY'18]

RetinAI has been selected as one of the TOP50 Swiss startups in which to invest by the Bilan Magazine. The committee of experts evaluated the progress and projection of hundreds of startups from the Swiss ecosystem and selected the 50 most promising technologies for 2018! Congratulations to the team for this great success.

Read more

‍

Venture Kick Phase III [DECEMBER'17]

Early detection of eye diseases is key for effective treatment to reduce the onset of blindness. However, the patient’s journey to diagnosis is often long and involves many challenges. Venture Kick just awarded RetinAI with 130'000.- CHF to make eye care accessible and affordable to everyone via artificial intelligence.

Read more

Our latest
Press Releases & Updates

Latest press releases

RetinAI Announces Strategic Partnership with Eyestem to Innovate Geographic Atrophy Clinical Research Using State-of-the-Art AI Technology

RetinAI and Retina Consultants of America Join Forces to build the Most Comprehensive U.S.-based Real World Evidence Database in Ophthalmology

RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence

RetinAI’s AI Algorithms Enrich Clinical Research and Improve Patient Care

Latest updates

124E International Congress de la SFO [MAY'18]

ARVO 2018 Honolulu - Hawaï [APRIL-MAY'18]

Bilan Magazine TOP 50 Startups in which to invest 2018 [FEBRUARY'18]

Venture Kick Phase III [DECEMBER'17]

Contact us for more informations! We are happy to hear from you!

Sign Up And Receive Our Latest Promotions!

Our latest Press Releases & Updates

Latest press releases

RetinAI Announces Strategic Partnership with Eyestem to Innovate Geographic Atrophy Clinical Research Using State-of-the-Art AI Technology

RetinAI and Retina Consultants of America Join Forces to build the Most Comprehensive U.S.-based Real World Evidence Database in Ophthalmology

RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence

RetinAI’s AI Algorithms Enrich Clinical Research and Improve Patient Care

Latest updates

124E International Congress de la SFO [MAY'18]

ARVO 2018 Honolulu - Hawaï [APRIL-MAY'18]

Bilan Magazine TOP 50 Startups in which to invest 2018 [FEBRUARY'18]

Venture Kick Phase III [DECEMBER'17]

Contact us for more informations! We are happy to hear from you!

Our latest
Press Releases & Updates